Alexander Brill

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Pulmonary Embolism

Inferior Vena Cava

Postoperative Pain

Top Venues

Research and practice in thrombosis and haemostasis

Communications materials

Harvard Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School Nov 01 2011 - Mar 24 2013

United States

Instructor

Harvard Medical School

United States

Postdoctoral Fellow

Publications

Christopher W Smith, Joana Campos, Helena C Brown, Natalie J Jooss, Vanesa-Sindi Ivanova, Maan H Harbi, Lourdes Garcia Quintanilla, Sian Jossi, Marisol Perez-Toledo, Kieran Rookes, Alexander Brill, Lindsay N Theodore, Timothy D Owens, Jacob J La Stant, Matthew C Foulke, Shin Mukai, Michelle Francesco, Michael J Storek, Alexandra Hicks, Claire Langrish, Philip A Nunn, Adam F Cunningham, Abhishek Chauhan, Mark R Thomas, Stephen P Watson, Phillip Lindsay Ross Nicolson
Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 & PRN473 reduces venous thrombosis formation in mice. Blood advances (2024)
Julie Rayes, Alexander Brill
Hot under the clot: venous thrombogenesis is an inflammatory process. Blood 144 (5) (2024)
Julie Rayes, Alexander Brill
Hot under the clot: venous thrombogenesis is an inflammatory process. Blood (2024)
Zoe Schofield, Hosam Alden Baksamawi, Joana Campos, Alessio Alexiadis, Gerard B Nash, Alexander Brill, Daniele Vigolo
The role of valve stiffness in the insurgence of deep vein thrombosis. Communications materials 1 (1) (2020)
Julie Rayes, Joshua H Bourne, Alexander Brill, Stephen P Watson
The dual role of platelet-innate immune cell interactions in thrombo-inflammation. Research and practice in thrombosis and haemostasis 4 (1) (2019)
Holly Payne, Tatyana Ponomaryov, Stephen P Watson, Alexander Brill
Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Blood 129 (14) (2017)